A combination treatment utilizing aCD73 and aPD-L1 antibodies (aCD73+aPD-L1) afforded similar levels of tumor growth control to anti-PD-L1 alone, highlighting the importance of the chemotherapy component within the chemotherapy+IO combination (Figure S1A and S1B). The gene discussed is CD274; the disease is neoplasm.